FindTrial
Sign In

Influence of Epstein-Barr virus infection on surgical risk and construction of surgical risk prediction model in patients with moderate-to-severe ulcerative colitis

Influence of Epstein-Barr virus infection on surgical risk and construction of surgical risk prediction model in patients with moderate-to-severe ulcerative colitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099230
Enrollment
Unknown
Registered
2025-03-20
Start date
2023-03-10
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

Moderate to severe UC patient group:None

Sponsors

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inpatients who were diagnosed with moderate to severe ulcerative colitis and had colonoscopy biopsy or surgical pathology report in Renji Hospital from September 1, 2012 to May 31, 2023.

Exclusion criteria

Exclusion criteria: Patients with unclear pathological diagnosis or exclusion of UC; UC patients undergoing surgery for cancer or adenoma; Patients who refuse medical salvage treatment for personal reasons; The clinical data record is unknown or missing patient.

Design outcomes

Primary

MeasureTime frame
Epstein-Barr virus;Area under the receiver operating characteristic curve;—

Secondary

MeasureTime frame
Cytomegalovirus;Decision curve analysis;Calibration curve;—

Countries

China

Contacts

Public ContactZhijun Cao

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

caozj_renji@163.com+86 136 4178 8722

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026